Both IPOs are among the most awaited listings of 2025, reflecting the growing investor appetite for homegrown tech-driven ...
Asianet Newsable on MSN
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing
Femasys secured FDA approval to proceed with the final phase of its pivotal FemBloc trial, a key step toward U.S. market ...
The IPO of Lenskart Solutions Ltd remains strong as it heads into the final day of bidding. The issue, which opened on October 31, has been subscribed to 2.15 t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback